16.04.2020
- French pharma Servier has agreed to buy Danish biotech Symphogen for an undisclosed sum. Headquartered in Copenhagen, Symphogen has created an antibody discovery and research...
19.11.2019
- French drugmaker Servier has acquired blood cancer treatment Pixuvri from US-based CTI BioPharma for an undisclosed sum. Pixuvri is a treatment for adults with multiply relapsed or...
04.09.2018
- Ahead of its acquisition by Japan’s Takeda Pharmaceutical, Ireland-domiciled, London-listed and US-focused Shire has completed the sale of its oncology portfolio with $262 million...
18.04.2018
- Ireland-based drugs giant Shire is selling its oncology business to France’s Servier in a deal worth $2.4 billion. The sale comes just as Japan’s Takeda Pharmaceutical was reported...
15.02.2016
- Major UK drugs firm GlaxoSmithKline (GSK) has been fined more than £37 million by the Competition and Markets Authority (CMA) for anti-competitive behavior relating to generic...
20.06.2013
- European antitrust regulators fined nine drugmakers, including Denmark's Lundbeck, a total of €146 million ($195 million) for blocking the supply of a cheaper anti-depressant to...
03.06.2013
- A European regulator will fine Denmark's Lundbeck and eight other makers of generic drugs for limiting the supply of cheaper medicines, two people with knowledge of the matter said...
